Should You Buy Neil Woodford’s China-Proof Shares Imperial Tobacco Group PLC, AstraZeneca plc And BT Group plc?

Neil Woodford’s top holdings Imperial Tobacco Group PLC (LON:IMT), AstraZeneca plc (LON:AZN) and BT Group plc (LON:BT.A) are an antidote to his concerns about China.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Renowned fund manager Neil Woodford has been concerned for some time about the Chinese economy, and what it means for the global economy as a whole. He discusses the subject in some detail in a blog post today.

Woodford suggests that recent growth figures coming out of China have lacked credibility when compared with other real economic data, noting:

“Even the Chinese Premier, Li Keqiang, allegedly mistrusts the country’s official economic statistics, preferring to track growth by looking at real data. The Li Keqiang Index, as it has become known, tracks growth in outstanding bank loans, electricity production and rail freight volumes, and currently shows a reading of just 2.5% year-on-year. It last visited that level in November 2008, just after Lehman collapsed”.

Woodford suggests that the number of reasons to be cautious about China is increasing. He particularly highlights what will be an inevitably long and bumpy transition from heavy infrastructure investment to a more Western consumption-based economy. Furthermore, he reckons the State is struggling to adopt the required political approach for such a transition, as demonstrated by recent interventions in the stock and currency markets.

The level of private sector debt in the Chinese economy is another big concern Woodford highlights. He says the level is “alarming” and suggests that the Chinese economy will have to go through “a period of prolonged debt moderation”. He also notes that China has scope to lower interest rates, which could export deflation to the rest of the world, with “signification ramifications for the global economic outlook”.

Woodford-watchers will know he has been concerned about the risks emanating from China for some years, and has built his portfolios in the expectation that there’ll be little help from macroeconomic tailwinds. As such, he has populated his portfolios with companies that are more in control of their own destinies — avoiding, oil companies, miners and banks.

The top holding in Woodford’s equity income fund, Imperial Tobacco (LSE: IMT), is a prime example of a company more in control of its own destiny. Tobacco consumption is not really dependent on buoyant economies. The industry does face some headwinds, caused by increased health awareness in developed countries, but Woodford reckons the prospects and cash-generative qualities of tobacco companies continue to be under-appreciated by the market. Imperial trades on a forward P/E of 15 and offers a prospective 4.4% dividend yield, which looks attractive for such a “defensive” company.

Woodford’s no. two holding AstraZeneca (LSE: AZN) may be at the other end of the health spectrum to Imperial, but it also has solid defensive qualities. In addition, the big pharma company should benefit from demographic trends of ageing populations. Woodford believes Astra did the right thing in rejecting a £55 a share takeover bid by US giant Pfizer last year. With the shares now trading at under £42 (forward P/E 16, yield 4.2%) you have an idea of how much value Woodford sees in the company.

BT (LSE: BT-A) is another of Woodford’s top five holdings. Increasingly, packages of fixed line, mobile, broadband and pay-TV are becoming more of a staple for consumers than a luxury. BT’s agreed acquisition of mobile group EE will extend the group’s capabilities, and, after some initial concerns, Woodford decided that the acquisition was a good move for BT and its shareholders. If he’s right, BT’s current forward P/E of 13 and yield of 3.5% represent excellent value.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Here’s what dividend forecasts could do for the BP share price in the next three years

I can understand why the BP share price is low, as oil's increasingly seen as evil. But BP's a cash…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

This FTSE 100 Dividend Aristocrat is on sale now

Stephen Wright thinks Croda International’s impressive dividend record means it could be the best FTSE 100 stock to add to…

Read more »

Investing Articles

3 shares I’d buy for passive income if I was retiring early

Roland Head profiles three FTSE 350 dividend shares he’d like to buy for their passive income to support an early…

Read more »

Investing Articles

Here’s how many Aviva shares I’d need for £1,000 a year in passive income

Our writer has been buying shares of this FTSE 100 insurer, but how many would he need to aim for…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

1 incredible growth stock I can’t find on the FTSE 100

The FTSE 100 offers us a lot of interesting investment opportunities, but there's not much in the way of traditional…

Read more »

Mature Caucasian woman sat at a table with coffee and laptop while making notes on paper
Investing Articles

With an £8K lump sum, I could create an annual second income worth £5,347

This Fool explains how a second income is achievable by using a lump sum, investing in stocks, and the magic…

Read more »

Investing Articles

Here’s what dividend forecasts could do for the BT share price in the next 3 years

With the BT share price down so low, the dividend looks very nice indeed. The company's debt is off-putting, though.…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

28% revenue growth per year and down over 20% in price! Should I invest in this niche FTSE 250 company?

Oliver says this FTSE 250 company has done an excellent job bringing auctioning into the modern world. Will he invest…

Read more »